Skip to content

Research & Literature

Last updated:

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature

Visualize citation networks across 93 referenced papers

Top Authors

Top Institutions

References

  1. 1

    Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series.

    Monti S, Montecucco C, Pieropan S, et al.

    Clinical and experimental rheumatology 2015; (33(2 Suppl 89)):S-126-31 doi:10.1136/annrheumdis-2015-eular.5151.

    PMID: 26016763
  2. 2

    GRANULOMATOSIS WITH POLYANGIITIS IN PUERTO RICO: CASE REPORTS.

    Aranguren L, Izquierdo NJ, Oliver A

    Boletin de la Asociacion Medica de Puerto Rico 2014; (106(4)):31-4.

    PMID: 26148397
  3. 3

    Atypical Endobronchial Carcinoid with Postobstructive Pneumonia Obscuring the Diagnosis of Granulomatosis with Polyangiitis.

    Ali R, Baldeo C, Onyenekwe J, et al.

    Case reports in rheumatology 2015; (2015()):513602 doi:10.1155/2015/513602.

    PMID: 26347844
  4. 4

    Wegener granulomatosis as possible cause of vertigo: case report and review.

    Goderis J, De Schepper S, Vannieuwenhuyze P, Schmelzer B

    B-ENT 2015; (11(1)):67-72.

    PMID: 26513951
  5. 5

    Clinic manifestations in granulomatosis with polyangiitis.

    Greco A, Marinelli C, Fusconi M, et al.

    International journal of immunopathology and pharmacology 2016; (29(2)):151-9 doi:10.1177/0394632015617063.

    PMID: 26684637
  6. 6

    Granulomatosis with polyangiitis and facial palsy: Literature review and insight in the autoimmune pathogenesis.

    Iannella G, Greco A, Granata G, et al.

    Autoimmunity reviews 2016; (15(7)):621-31.

    PMID: 26851550
  7. 7

    RITUXIMAB: THE DRUG THAT NEVER FAILS TO SURPRISE!

    Seth AA, Patel S, Gangam MA, Hayat SQ

    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 2015; (167(3)):153.

    PMID: 27159476
  8. 8

    Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.

    Miloslavsky EM, Lu N, Unizony S, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2016; (68(12)):2945-2952 doi:10.1002/art.39812.

    PMID: 27428559
  9. 9

    Overview of the Pathogenesis of ANCA-Associated Vasculitis.

    Xiao H, Hu P, Falk RJ, Jennette JC

    Kidney diseases (Basel, Switzerland) 2016; (1(4)):205-15 doi:10.1159/000442323.

    PMID: 27536680
  10. 10

    [Pulmonar pseudotumor in granulomatosis with polyangiitis (GPA). Pulmonary cancer and/or GPA? Diagnostic implications of pulmonary nodules].

    Horta-Baas G, Meza-Zempoaltecatl E, Pérez-Cristóbal M, Barile-Fabris LA

    Gaceta medica de Mexico 2016; (152(4)):521-8.

    PMID: 27595257
  11. 11

    ANCA-associated vasculitis.

    Yates M, Watts R

    Clinical medicine (London, England) 2017; (17(1)):60-64 doi:10.7861/clinmedicine.17-1-60.

    PMID: 28148583
  12. 12

    An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.

    Surendran S, Gundappa C, Gandhi A, et al.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2017; (28(3)):639-644 doi:10.4103/1319-2442.206450.

    PMID: 28540906
  13. 13

    ANCA-associated vasculitis with renal involvement.

    Binda V, Moroni G, Messa P

    Journal of nephrology 2018; (31(2)):197-208 doi:10.1007/s40620-017-0412-z.

    PMID: 28560688
  14. 14

    Granulomatosis with Polyangiitis with Myocarditis and Ventricular Tachycardia.

    Hanna RM, Lopez E, Wilson J

    Case reports in medicine 2017; (2017()):6501738 doi:10.1155/2017/6501738.

    PMID: 28912820
  15. 15

    Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.

    Maritati F, Alberici F, Oliva E, et al.

    PloS one 2017; (12(10)):e0185880 doi:10.1371/journal.pone.0185880.

    PMID: 29016646
  16. 16

    Relapsing granulomatosis with polyangiitis with severe lung and upper respiratory tract involvement successfully treated with rituximab.

    Masiak A, Zdrojewski Z

    Reumatologia 2017; (55(4)):208-212 doi:10.5114/reum.2017.69783.

    PMID: 29056777
  17. 17

    Anti-neutrophil cytoplasmic antibodies and their clinical significance.

    Suwanchote S, Rachayon M, Rodsaward P, et al.

    Clinical rheumatology 2018; (37(4)):875-884 doi:10.1007/s10067-018-4062-x.

    PMID: 29525845
  18. 18

    Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis.

    Yoo J, Ahn SS, Jung SM, et al.

    Yonsei medical journal 2018; (59(3)):397-405 doi:10.3349/ymj.2018.59.3.397.

    PMID: 29611402
  19. 19

    A clinical threat in patients with granulomatosis polyangiitis in remission: Subglottic stenosis.

    Ugan Y, Doğru A, Aynalı G, et al.

    European journal of rheumatology 2018; (5(1)):69-71 doi:10.5152/eurjrheum.2017.16025.

    PMID: 29657878
  20. 20

    Severe localised granulomatosis with polyangiitis (Wegener's granulomatosis) manifesting with extensive cranial nerve palsies and cranial diabetes insipidus: a case report and literature review.

    Peters JE, Gupta V, Saeed IT, et al.

    BMC neurology 2018; (18(1)):59 doi:10.1186/s12883-018-1058-8.

    PMID: 29716529
  21. 21

    Targeted immunotherapy strategies in ANCA-associated vasculitis.

    Puéchal X

    Joint bone spine 2019; (86(3)):321-326 doi:10.1016/j.jbspin.2018.09.002.

    PMID: 30201478
  22. 22

    Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.

    Lynch JP, Derhovanessian A, Tazelaar H, Belperio JA

    Seminars in respiratory and critical care medicine 2018; (39(4)):434-458 doi:10.1055/s-0038-1660874.

    PMID: 30404111
  23. 23

    A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.

    Quan MV, Frankel SK, Maleki-Fischbach M, Tan LD

    BMC pulmonary medicine 2018; (18(1)):181 doi:10.1186/s12890-018-0733-2.

    PMID: 30497438
  24. 24

    Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Causes Aortic Valve Degeneration and Severe Aortic Regurgitation.

    Guterbaum TJ, Husic M, Voss A, Dahl JS

    The American journal of case reports 2019; (20()):423-429 doi:10.12659/AJCR.912693.

    PMID: 30930460
  25. 25

    18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Assessment of Occult Involvement in Widespread Granulomatosis with Polyangiitis (Wegener's Granulomatosis).

    Saleh Farghaly HR, Alqarni AO, Nasr HA

    Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India 2019; (34(2)):153-156 doi:10.4103/ijnm.IJNM_151_18.

    PMID: 31040531
  26. 26

    Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

    Morishita M, Sada KE, Matsumoto Y, et al.

    PloS one 2019; (14(7)):e0218705 doi:10.1371/journal.pone.0218705.

    PMID: 31291263
  27. 27

    ANCA-Associated Vasculitis: Core Curriculum 2020.

    Geetha D, Jefferson JA

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2020; (75(1)):124-137 doi:10.1053/j.ajkd.2019.04.031.

    PMID: 31358311
  28. 28

    Remission maintenance in ANCA-associated vasculitis: does one size fit all?

    Berti A, Specks U

    Expert review of clinical immunology 2019; (15(12)):1273-1286 doi:10.1080/1744666X.2020.1693260.

    PMID: 31762340
  29. 29

    Measuring Vasculitis with Numbers: Outcome Scores.

    Batu ED, Ozen S

    Current rheumatology reviews 2020; (16(1)):21-28 doi:10.2174/1573397115666191126093927.

    PMID: 31804163
  30. 30

    Elevated levels of d-dimer are associated with inflammation and disease activity rather than risk of venous thromboembolism in patients with granulomatosis with polyangiitis in long term observation.

    Borowiec A, Dąbrowski R, Kowalik I, et al.

    Advances in medical sciences 2020; (65(1)):97-101 doi:10.1016/j.advms.2019.12.007.

    PMID: 31923773
  31. 31

    Monitoring the activity of anca-associated vasculitis: some questionnaires and laboratory parameters

    Suszek D, Majdan M, Widłak K, et al.

    Wiadomosci lekarskie (Warsaw, Poland : 1960) 2019; (72(10)):2010-2016.

    PMID: 31983066
  32. 32

    Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy.

    Novikov P, Kozlovskaya N, Moiseev S, et al.

    Biomedicine hub 2016; (1(3)):1-11 doi:10.1159/000453106.

    PMID: 31988889
  33. 33

    High incidence of venous thromboembolism but not of coronary artery disease in granulomatosis with polyangiitis in first years after diagnosis.

    Borowiec A, Hadzik-Błaszczyk M, Kowalik I, et al.

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2019; (36(3)):202-208 doi:10.36141/svdld.v36i3.8088.

    PMID: 32476955
  34. 34

    Abdominal Pain, an Atypical Presenting Symptom of Granulomatosis with Polyangiitis.

    Desai K, Jose M, Ogbebor O

    Cureus 2020; (12(4)):e7864 doi:10.7759/cureus.7864.

    PMID: 32483514
  35. 35

    How to improve the histopathological diagnosis of systemic vasculitides in daily practice?

    Honsová E

    Ceskoslovenska patologie 2020; (56(2)):68-73.

    PMID: 32493022
  36. 36

    Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment.

    Sattui SE, Lally L

    Current allergy and asthma reports 2020; (20(10)):56 doi:10.1007/s11882-020-00953-1.

    PMID: 32648055
  37. 37

    New lung mass in a patient with granulomatosis with polyangiitis.

    Masiak A, Fijałkowska J, Nowakowski S, et al.

    Rheumatology international 2021; (41(2)):493-499 doi:10.1007/s00296-020-04646-w.

    PMID: 32671469
  38. 38

    Plasma exchange for the management of ANCA-associated vasculitis: the con position.

    Specks U, Fussner LA, Cartin-Ceba R, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2021; (36(2)):231-236 doi:10.1093/ndt/gfaa312.

    PMID: 33374017
  39. 39

    Plasma exchange in ANCA-associated vasculitis: the pro position.

    Kronbichler A, Shin JI, Wang CS, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2021; (36(2)):227-231 doi:10.1093/ndt/gfaa311.

    PMID: 33374018
  40. 40

    [Cortisone-free rheumatology-Vasculitides].

    Holle JU, Moosig F

    Zeitschrift fur Rheumatologie 2021; (80(4)):314-321 doi:10.1007/s00393-021-00974-9.

    PMID: 33709164
  41. 41

    Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis.

    Ahn SS, Yoon T, Song JJ, et al.

    In vivo (Athens, Greece) 2021; (35(3)):1761-1768 doi:10.21873/invivo.12435.

    PMID: 33910860
  42. 42

    Granulomatosis with Polyangiitis: Recurrence or Treatment Consequences?

    Diegues A, Tavares J, Sá D, et al.

    European journal of case reports in internal medicine 2021; (8(4)):002448 doi:10.12890/2021_002448.

    PMID: 33987124
  43. 43

    Tumor-like Lesions in Patients with Granulomatosis with Polyangiitis: A Case Series.

    Gendelman O, Kuntzman Y, Shovman O, et al.

    The Israel Medical Association journal : IMAJ 2021; (23(6)):350-352.

    PMID: 34155847
  44. 44

    Granulomatous Inflammation in ANCA-Associated Vasculitis.

    Müller A, Krause B, Kerstein-Stähle A, et al.

    International journal of molecular sciences 2021; (22(12)) doi:10.3390/ijms22126474.

    PMID: 34204207
  45. 45

    Consideration of Therapeutic Plasma Exchange in Association With Inflammatory Lesions in ANCA-Associated Glomerulonephritis: A Real-World Retrospective Study From a Single Center.

    Tampe D, Ströbel P, Korsten P, et al.

    Frontiers in immunology 2021; (12()):645483 doi:10.3389/fimmu.2021.645483.

    PMID: 34220805
  46. 46

    Granulomatosis with polyangiitis: A case report and brief review of literature.

    Lakhani DA, Balar AB, Adelanwa A, et al.

    Radiology case reports 2021; (16(11)):3445-3450 doi:10.1016/j.radcr.2021.08.028.

    PMID: 34527120
  47. 47

    Epidemiology and genetics of granulomatosis with polyangiitis.

    Banerjee P, Jain A, Kumar U, Senapati S

    Rheumatology international 2021; (41(12)):2069-2089 doi:10.1007/s00296-021-05011-1.

    PMID: 34635927
  48. 48

    Plasma Exchange in ANCA-Associated Vasculitis: A Narrative Review.

    Tsiakas S, Marinaki S, Lionaki S, Boletis J

    Journal of clinical medicine 2021; (10(21)) doi:10.3390/jcm10215154.

    PMID: 34768675
  49. 49

    Avacopan: First Approval.

    Lee A

    Drugs 2022; (82(1)):79-85 doi:10.1007/s40265-021-01643-6.

    PMID: 34826105
  50. 50

    Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.

    Wójcik K, Masiak A, Jeleniewicz R, et al.

    Polish archives of internal medicine 2022; (132(3)) doi:10.20452/pamw.16187.

    PMID: 34985235
  51. 51

    ANCA-Associated Vasculitic Neuropathies: A Review.

    Koike H, Nishi R, Ohyama K, et al.

    Neurology and therapy 2022; (11(1)):21-38 doi:10.1007/s40120-021-00315-7.

    PMID: 35044596
  52. 52

    [Update on etiopathogenesis of small vessel vasculitis].

    Arnold S, Holl-Ulrich K, Müller A, et al.

    Zeitschrift fur Rheumatologie 2022; (81(4)):270-279 doi:10.1007/s00393-021-01155-4.

    PMID: 35084556
  53. 53

    Recent Advancements in the Management of Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Systematic Review.

    Arzoun H, Srinivasan M, Thangaraj SR, et al.

    Cureus 2022; (14(2)):e21814 doi:10.7759/cureus.21814.

    PMID: 35155037
  54. 54

    Antineutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis localized to the lungs.

    Ohteru Y, Hamada K, Oishi K, et al.

    Respiratory medicine case reports 2022; (36()):101600 doi:10.1016/j.rmcr.2022.101600.

    PMID: 35169540
  55. 55

    A Rare Case of Nephrotic-Range Proteinuria in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.

    Nasr R, Balasubramanian P, Desiderio L, Abdelattif M

    Cureus 2022; (14(5)):e24889 doi:10.7759/cureus.24889.

    PMID: 35572457
  56. 56

    [ANCA-Associated Vasculitides].

    Stegert M, Neumann T, Daikeler T

    Therapeutische Umschau. Revue therapeutique 2022; (79(5)):229-237 doi:10.1024/0040-5930/a001355.

    PMID: 35583025
  57. 57

    Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis.

    Tsuboi K, Noguchi K, Kitano M, et al.

    Immunological medicine 2022; (45(4)):238-243 doi:10.1080/25785826.2022.2094592.

    PMID: 35802795
  58. 58

    ANCA associated vasculitis (AAV): a review for internists.

    Yaseen K, Mandell BF

    Postgraduate medicine 2023; (135(sup1)):3-13 doi:10.1080/00325481.2022.2102368.

    PMID: 35831990
  59. 59

    Migrant cavitation as primary involvement in a particular case of granulomatosis with polyangiitis.

    Manti F, Battaglia C, Pelaia C, et al.

    Radiology case reports 2022; (17(10)):3535-3538 doi:10.1016/j.radcr.2022.06.074.

    PMID: 35923342
  60. 60

    [ANCA-associated vasculitis].

    Krasselt ML, Holle JU

    Innere Medizin (Heidelberg, Germany) 2022; (63(9)):947-960 doi:10.1007/s00108-022-01386-w.

    PMID: 35925127
  61. 61

    [Granulomatous vasculitides and vasculitides with extravascular granulomatosis].

    Arnold S, Klapa S, Holl-Ulrich K, et al.

    Zeitschrift fur Rheumatologie 2022; (81(7)):558-566 doi:10.1007/s00393-022-01249-7.

    PMID: 35962194
  62. 62

    Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management.

    Ge S, Zhu X, Xu Q, et al.

    Frontiers in pharmacology 2022; (13()):957660 doi:10.3389/fphar.2022.957660.

    PMID: 36210838
  63. 63

    Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis.

    Konstantouli AM, Lioulios G, Stai S, et al.

    Life (Basel, Switzerland) 2022; (12(10)) doi:10.3390/life12101467.

    PMID: 36294902
  64. 64

    Granulomatosis With Polyangiitis: A Clinical Case.

    Rodrigues F, Oliveira Sá AI, Mendes M, et al.

    Cureus 2022; (14(12)):e32410 doi:10.7759/cureus.32410.

    PMID: 36636531
  65. 65

    Oral manifestations of anti-neutrophil cytoplasmic antibody-associated vasculitis: an update and narrative review of the literature.

    Alamoudi WA, Sollecito TP, Stoopler ET, France K

    Oral surgery, oral medicine, oral pathology and oral radiology 2023; (135(3)):372-384 doi:10.1016/j.oooo.2022.11.013.

    PMID: 36639252
  66. 66

    An update on dıagnosıs and treatment of ANCA assocıated renal vasculıtıs.

    Turkmen K, Ozer H, Tesar V

    International urology and nephrology 2023; (55(11)):2817-2827 doi:10.1007/s11255-023-03565-6.

    PMID: 37010734
  67. 67

    A Runny Nose Leads to a Rare Diagnosis: Chronic Sinusitis as a Sole Manifestation of Limited Granulomatosis With Polyangiitis.

    Qudsiya Z, Viqas Z, Baker DL

    Cureus 2023; (15(5)):e39203 doi:10.7759/cureus.39203.

    PMID: 37337503
  68. 68

    [Pharmacological and clinical profiles of avacopan (TAVNEOS® capsule), a selective C5a receptor antagonist].

    Maruyama Y, Yoshida T, Maruyama I

    Nihon yakurigaku zasshi. Folia pharmacologica Japonica 2023; (158(5)):399-407 doi:10.1254/fpj.22161.

    PMID: 37460300
  69. 69

    Subglottic Stenosis as a Presentation of Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.

    Patrick Eisenberg A, Collier V, Mangano A, et al.

    Cureus 2023; (15(10)):e46899 doi:10.7759/cureus.46899.

    PMID: 37954789
  70. 70

    Diagnosis and management of facial nerve palsy secondary to granulomatosis with polyangiitis - A systematic review.

    Odom JQ, Mangan AR, Gibson AC, et al.

    American journal of otolaryngology 2024; (45(2)):104132 doi:10.1016/j.amjoto.2023.104132.

    PMID: 38039912
  71. 71

    [Granulomatosis with polyangiitis and microscopic polyangiitis].

    Klapa S, Arnold S, Lamprecht P

    Laryngo- rhino- otologie 2024; (103(7)):490-499 doi:10.1055/a-2217-4457.

    PMID: 38211619
  72. 72

    Diagnosis and management of ANCA-associated vasculitis.

    Kronbichler A, Bajema IM, Bruchfeld A, et al.

    Lancet (London, England) 2024; (403(10427)):683-698 doi:10.1016/S0140-6736(23)01736-1.

    PMID: 38368016
  73. 73

    A Rare Case of Granulomatosis With Polyangiitis Complicated by Splenic Rupture.

    Awad OM, Srour IA, Mekdad FA, et al.

    Cureus 2024; (16(1)):e52536 doi:10.7759/cureus.52536.

    PMID: 38371079
  74. 74

    Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis.

    Falde SD, Fussner LA, Tazelaar HD, et al.

    The Lancet. Rheumatology 2024; (6(5)):e314-e327 doi:10.1016/S2665-9913(24)00035-3.

    PMID: 38574742
  75. 75

    Granulomatosis With Polyangiitis: Cardiac, Renal, and Respiratory Involvement.

    Khatiwala P, Patel P, Nachodsky A

    Cureus 2024; (16(6)):e61529 doi:10.7759/cureus.61529.

    PMID: 38957259
  76. 76

    Ocular manifestations in ANCA-associated vasculitis: a comprehensive analysis from Chinese medical centers.

    Liu S, Xu M, Zhao X, et al.

    Clinical rheumatology 2024; (43(9)):2899-2910 doi:10.1007/s10067-024-07034-y.

    PMID: 39002071
  77. 77

    Dacryoadenitis: do not forget ANCA vasculitis.

    Derbel A, Salah RB, Boukhzar R, et al.

    Romanian journal of ophthalmology 2024; (68(2)):187-190 doi:10.22336/rjo.2024.35.

    PMID: 39006332
  78. 78

    Update on targeted treatments for ANCA-associated vasculitis.

    Puéchal X

    Joint bone spine 2025; (92(1)):105768 doi:10.1016/j.jbspin.2024.105768.

    PMID: 39089473
  79. 79

    Undisclosed facts in Friedrich Wegener's links with Nazism.

    Arkuszewski P, Cieślak-Arkuszewska A

    Histopathology 2025; (86(3)):317-326 doi:10.1111/his.15296.

    PMID: 39104223
  80. 80

    Superiority of Avacopan and Mepolizumab to Glucocorticoid Tapering in the Treatment of Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Systematic Review.

    Gattu R, Demory Beckler M, Kesselman MM

    Cureus 2024; (16(8)):e67161 doi:10.7759/cureus.67161.

    PMID: 39295694
  81. 81

    Granulomatosis With Polyangiitis Misdiagnosed as Tuberculosis: A Case Report.

    Martins JD, Soares C, Barreiros C, et al.

    Cureus 2024; (16(10)):e71834 doi:10.7759/cureus.71834.

    PMID: 39559674
  82. 82

    Granulomatosis with Polyangiitis: A Focus on Differences and Similarities Between Child and Adult Patients.

    Calabrese V, Gallizzi R, Spagnolo A, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(3)) doi:10.3390/medicina61030534.

    PMID: 40142345
  83. 83

    Thoracic Manifestations of ANCA-associated Vasculitis: Review of the 2022 American College of Rheumatology-European Alliance of Associations of Rheumatology Classification Criteria.

    Kwon J, Choi YW, Kim H, Yoo SJ

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(4)):e240089 doi:10.1148/rg.240089.

    PMID: 40146625
  84. 84

    Laryngeal Frame Involvement as The First Sign of Wegener's Granulomatosis.

    Burrascano D, Verro B, Ottoveggio G, et al.

    Iranian journal of otorhinolaryngology 2025; (37(2)):95-98 doi:10.22038/ijorl.2024.81617.3746.

    PMID: 40162375
  85. 85

    Safety of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Combined Data From Three Clinical Trials.

    Merkel PA, George MD, Yue H, et al.

    ACR open rheumatology 2025; (7(4)):e70001 doi:10.1002/acr2.70001.

    PMID: 40192160
  86. 86

    Drug-induced liver injury due to avacopan improved by mycophenolate mofetil: A case report.

    Yamashita R, Izumi Y, Takane K, et al.

    Medicine 2025; (104(15)):e42121 doi:10.1097/MD.0000000000042121.

    PMID: 40228281
  87. 87

    A Rare Case of Granulomatosis With Polyangiitis With Cutaneous Pyoderma Gangrenosum-Like Lesions of the Bilateral Parotid Glands.

    Short SH, McGlone M, Ohlstein JF

    Ear, nose, & throat journal 2025; 1455613251345431 doi:10.1177/01455613251345431.

    PMID: 40658486
  88. 88

    [How do I treat ANCA vasculitis with renal involvement].

    Crucil M, Regnier C, Von Frenckell C, et al.

    Revue medicale de Liege 2025; (80(9)):556-562.

    PMID: 40931730
  89. 89

    Mapping a path forward: addressing disease burden, pathways and solutions in ANCA-associated vasculitis.

    Hellmich B

    Rheumatology (Oxford, England) 2026; (65(Supplement_1)):i1-i5 doi:10.1093/rheumatology/keaf517.

    PMID: 41051263
  90. 90

    Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide.

    Geetha D, Neumann T, Karras A, et al.

    RMD open 2025; (11(4)) doi:10.1136/rmdopen-2025-005743.

    PMID: 41052893
  91. 91

    ANCA-negative Pauci-immune Vasculitis, an Often-missed Clinical Entity: A Case Report.

    Tudu A, Paul S, Ghosh UC, Banerjee B

    The Journal of the Association of Physicians of India 2025; (73(11S)):40-42 doi:10.59556/japi.73.1245.

    PMID: 41296302
  92. 92

    Granulomatosis With Polyangiitis (Wegener Granulomatosis): Then and Now.

    Churg A, Muller NL

    Archives of pathology & laboratory medicine 2025; (150(1)):37-43 doi:10.5858/arpa.2025-0146-RA.

    PMID: 41429180
  93. 93

    Expanding the Role of Avacopan Beyond Renal Involvement: Clinical Insights from Two Cases.

    Henriques AR, Oliveira N, Castro P, et al.

    Modern rheumatology case reports 2026; doi:10.1093/mrcr/rxag022.

    PMID: 41800550